Awards and Recognitions - Juniper Biologics

We are honoured to have been named the Most Innovative Oncology Pharmaceutical Company 2023 at the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards!

By Juniper Biologics / October 23, 2023 / Comments Off

This achievement is a testament to the relentless dedication and pioneering spirit of our team. Our commitment to advancing oncology support and improving the quality of life of patients suffering from cancer continues to drive us every day. Read more about our recognition here. https://www.ghp-news.com/winners/juniper-biologics/

Raman Singh: Delivering Novel Therapies to Improve the Health and Quality of Life of Patients Everywhere – Worlds Leaders

By Juniper Biologics / February 15, 2023 / Comments Off

We are proud to announce that World’s Leaders Magazine has recognised our CEO Raman Singh as one of the World’s Influential Leaders Making an Impact in Pharma & Biotech. Raman is featured on the cover of the February edition discussing Juniper Biologics‘ commitment to delivering novel therapies to improve the health and quality of life of patients everywhere. Read it … Read more

Acquisition International Magazine’s M&A Award 2022 for Best Cell & Gene Therapy Acquisition 2022

By Juniper Biologics / December 27, 2022 / Comments Off

We’re proud to announce that we’ve won Acquisition International Magazine’s M&A Award 2022 for Best Cell & Gene Therapy Acquisition 2022, in recognition of our licensing deal for TG-C LD ! This acquisition was our first step in ensuring patients suffering from osteoarthritis receive the treatment they need and have the quality of life they deserve. … Read more